Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1970 1
1974 1
1980 1
1981 1
1983 2
1984 1
1985 3
1987 4
1988 1
1991 2
1992 1
1993 1
1996 2
1997 2
1999 5
2001 6
2002 7
2003 5
2004 12
2005 8
2006 11
2007 14
2008 23
2009 18
2010 16
2011 16
2012 4
2013 8
2014 11
2015 7
2016 10
2017 12
2018 12
2019 12
2020 11
2021 12
2022 21
2023 25
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.
Komura K, Inamoto T, Tsujino T, Matsui Y, Konuma T, Nishimura K, Uchimoto T, Tsutsumi T, Matsunaga T, Maenosono R, Yoshikawa Y, Taniguchi K, Tanaka T, Uehara H, Hirata K, Hirano H, Nomi H, Hirose Y, Ono F, Azuma H. Komura K, et al. Oncogene. 2021 Oct;40(43):6210-6222. doi: 10.1038/s41388-021-02021-y. Epub 2021 Sep 20. Oncogene. 2021. PMID: 34545188 Free PMC article.
Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancer.
Tsujino T, Tokushige S, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Ohno T, Nakamori K, Maenosono R, Nishimura K, Yamazaki S, Uchimoto T, Yanagisawa T, Mori K, Urabe F, Tsuzuki S, Iwatani K, Yamamoto S, Takahara K, Inamoto T, Kimura T, Ohno Y, Shiroki R, Azuma H. Tsujino T, et al. Among authors: komura k. Cancer Med. 2023 Oct;12(19):19414-19422. doi: 10.1002/cam4.6536. Epub 2023 Sep 14. Cancer Med. 2023. PMID: 37706578 Free PMC article.
Perspective to precision medicine in scleroderma.
Komura K, Yanaba K, Bouaziz JD, Yoshizaki A, Hasegawa M, Varga J, Takehara K, Matsushita T. Komura K, et al. Front Immunol. 2024 Jan 18;14:1298665. doi: 10.3389/fimmu.2023.1298665. eCollection 2023. Front Immunol. 2024. PMID: 38304250 Free PMC article.
Current treatment strategies for advanced prostate cancer.
Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW. Komura K, et al. Int J Urol. 2018 Mar;25(3):220-231. doi: 10.1111/iju.13512. Epub 2017 Dec 20. Int J Urol. 2018. PMID: 29266472 Free PMC article. Review.
Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review.
Tanaka T, Nishie R, Ueda S, Miyamoto S, Hashida S, Konishi H, Terada S, Kogata Y, Sasaki H, Tsunetoh S, Taniguchi K, Komura K, Ohmichi M. Tanaka T, et al. Among authors: komura k. J Clin Med. 2022 May 6;11(9):2606. doi: 10.3390/jcm11092606. J Clin Med. 2022. PMID: 35566732 Free PMC article. Review.
Can bladder preservation therapy come to the center stage?
Inamoto T, Ibuki N, Komura K, Juri H, Yamamoto K, Yamamoto K, Fujita K, Nonomura N, Narumi Y, Azuma H. Inamoto T, et al. Among authors: komura k. Int J Urol. 2018 Feb;25(2):134-140. doi: 10.1111/iju.13495. Epub 2017 Nov 23. Int J Urol. 2018. PMID: 29171098 Review.
283 results